Animas Corp., a Johnson & Johnson diabetes care company will leave the insulin pump market in the U.S. and Canada, and discontinue its Animas, Vibe and Onetouch Ping insulin pumps. The company will manage a transition to alternate devices for its patients, working with chosen partner, Medtronic plc, in that effort. Read More
